Table 1. Summary of indication on antiplatelet treatment from ESC guidelines 2017.
District involved | Monotherapy (aspirin or clopidogrel) | DAPT (aspirin plus clopidogrel) |
---|---|---|
LEAD | ||
Asymptomatic | Class III A | – |
Symptomatic | Class I A | – |
Endovascular revascularization | From 1 month after procedure: class IIa C | For 1 month after procedure: class IIa C |
Surgical revascularization | Class IIb B | – |
Carotid artery disease | ||
Asymptomatic (>50% carotid artery stenosis, low bleeding risk) | Class IIa C | – |
Symptomatic | Class I A | – |
Endovascular revascularization | From 1 month after procedure: class I A | For 1 month after procedure: class I A |
Surgical revascularization | Class I A | – |
ESC, European Society of Cardiology; LEAD, lower extremity.